Why the study?
Vulnerable carotid plaque rupture is an important cause of stroke, but the role of gemstone spectral imaging in assessing vulnerable carotid plaques has not been sufficiently explored.
Does gemstone spectral imaging combined with serological biomarkers accurately differentiate vulnerable from stable carotid atherosclerotic plaques?
Does gemstone spectral imaging combined with serological biomarkers accurately differentiate vulnerable from stable carotid atherosclerotic plaques?
Gemstone spectral imaging parameters (calcium content and spectral curve slope) combined with inflammatory biomarkers (Hs-CRP, MCP-1) can feasibly identify vulnerable carotid plaques.
Hypothesis-generating for spectral imaging plus biomarkers in carotid plaque assessment; prospective studies required before clinical adoption.
Growing evidence indicates that vulnerable carotid plaque rupture is an important cause of stroke. However, the role of novel gemstone spectral imaging (GSI) in the assessment of vulnerable carotid plaques has remained to be sufficiently explored. Therefore, the aim of the present study was to provide a comprehensive evaluation of carotid atherosclerotic plaques using both GSI imaging biomarkers and serological biomarkers, and further explore their possible roles in the atherogenic process. The present study analyzed GSI data, including calcium content of carotid atherosclerotic plaques and spectral curve slope, as well as serum high-sensitivity C-reactive protein (Hs-CRP) and monocyte chemotactic protein-1 (MCP-1) levels in patients with a carotid atherosclerotic plaque using GSI-computed tomographic angiography and immunoturbidimetry. Patients with unstable plaque exhibited a significantly lower calcium content and higher spectral curve slope than those of the stable plaque group. In addition, patients with unstable plaque exhibited an increase in Hs-CRP and MCP-1 levels compared with those of the stable plaque and normal control groups. The alteration in GSI calcium content and spectral curve slope reflects a close link between calcification and plaque instability, while aberrant Hs-CRP and MCP-1 expression are involved in the formation or development of vulnerable plaques. Taken together, the present results strongly support the feasibility of using these serological and newly identified imaging parameters as multiple potential biomarkers relevant to plaque vulnerability or stroke progression.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: